Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001144204-16-118191
Filing Date
2016-08-11
Accepted
2016-08-11 09:29:54
Documents
1
Effectiveness Date
2016-08-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11030
  Complete submission text file 0001144204-16-118191.txt   12222
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

EIN.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-268723 | Film No.: 161823183
SIC: 2835 In Vitro & In Vivo Diagnostic Substances